Genenta Science S.p.A.
GNTA
$1.60
-$0.20-11.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 39.43% | 41.02% | 0.09% | 8.15% | 1.23% |
| Total Depreciation and Amortization | -31.09% | -32.52% | -33.61% | -39.17% | 3.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.67% | 11.66% | 113.14% | 95.89% | 77.88% |
| Change in Net Operating Assets | 2,939.68% | 2,859.23% | -239.26% | -228.03% | -97.34% |
| Cash from Operations | 64.67% | 65.60% | -182.56% | -159.75% | -14.23% |
| Capital Expenditure | 100.00% | 100.00% | -330.00% | -300.00% | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -526.85% | -515.66% | -208.57% | -199.81% | 152.36% |
| Cash from Investing | -527.29% | -516.10% | -208.80% | -200.02% | 152.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 999.34% | 999.34% | -100.00% |
| Cash from Financing | -- | -- | 3,977.78% | 3,650.14% | -100.00% |
| Foreign Exchange rate Adjustments | 110.26% | 110.00% | 554.02% | 521.84% | -14.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.86% | 123.24% | -74.87% | -76.90% | 81.34% |